List View

By /

Clear

Displaying 1,751 - 1,775 of 2,995

Novel Advances in Mesothelioma

Novel Advances in Mesothelioma

ALK: Choosing 1L & Mechanism of Resistance

ALK: Choosing 1L & Mechanism of Resistance

Identifying and Targeting Mechanisms of Resistance to 3rd Generation EGFR Inhibitors

Identifying and Targeting Mechanisms of Resistance to 3rd Generation EGFR Inhibitors

Small Cell Lung Cancer: 1L and Beyond

Small Cell Lung Cancer: 1L and Beyond

Novel Treatment for Unresectable Stage III NSCLC

Novel Treatment for Unresectable Stage III NSCLC

Neoadjuvant and Adjuvant Immunotherapy in Early Stage Lung Cancer

Neoadjuvant and Adjuvant Immunotherapy in Early Stage Lung Cancer

K-RAS and ERBB2 Mutation in NSCLC

K-RAS and ERBB2 Mutation in NSCLC

EGFRex20ins, METex14 and RET in NSCLC

EGFRex20ins, METex14 and RET in NSCLC

ADC in NSCLC: TROP2 and HER3 in NSCLC

ADC in NSCLC: TROP2 and HER3 in NSCLC

ADC in NSCLC: CEACAM5 and Teliso-V

ADC in NSCLC: CEACAM5 and Teliso-V

T-Cell NHL: Novel Approaches & Challenges

T-Cell NHL: Novel Approaches & Challenges

Novel Therapeutic Advances for DLBCL & Hodgkin’s Disease

Novel Therapeutic Advances for DLBCL & Hodgkin’s Disease

Follicular Lymphoma: Defining Best 1L and 2L Treatment in the Era of Personalized Medicine

Follicular Lymphoma: Defining Best 1L and 2L Treatment in the Era of Personalized Medicine

The Art-of-Medicine in Treating Chronic Lymphocytic Leukemia

The Art-of-Medicine in Treating Chronic Lymphocytic Leukemia

Navigating Payor Barriers to Access of Oncology Pharmaceuticals: Real-World Case Approach

Navigating Payor Barriers to Access of Oncology Pharmaceuticals: Real-World Case Approach

De Novo Acute Myeloid Leukemia

De Novo Acute Myeloid Leukemia

Redefining Treatment Algorithms in B-cell Lymphomas: A Focus on CAR-T Cell TherapyLymphoma

Redefining Treatment Algorithms in B-cell Lymphomas: A Focus on CAR-T Cell TherapyLymphoma

Myelodysplastic Syndrome: Challenges, Current Standard Therapy and Future Directions

Myelodysplastic Syndrome: Challenges, Current Standard Therapy and Future Directions

Thrombophilia & Thrombosis in Cancer Patients: Novel Advances

Thrombophilia & Thrombosis in Cancer Patients: Novel Advances

How to Choose the Best 1L in a Newly Diagnosed Multiple Myeloma Patient?

How to Choose the Best 1L in a Newly Diagnosed Multiple Myeloma Patient?

How to Navigate Through Relapsed-Refractory Myeloma Patient

How to Navigate Through Relapsed-Refractory Myeloma Patient

Waldenstrom’s Macroglobulinemia

Waldenstrom’s Macroglobulinemia

Artificial Intelligence in Oncology Care

Artificial Intelligence in Oncology Care

Immunotherapy in Advanced/Metastatic NSCLC and What After IO Failures?

Immunotherapy in Advanced/Metastatic NSCLC and What After IO Failures?

How I Treat Multiple Myeloma in 2023

How I Treat Multiple Myeloma in 2023